Compliance Rate
Compliance Rate
48.0%
Compliant submissions
48
Incompliant submissions
52
Total trials
100
Your Clinical Trials
Showing 539275 of 542236 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 10/01/20
Due: 10/01/21
Phase: N/A
Priority: Normal
Start: 11/26/24
End: 01/17/25
Due: 01/17/26
Phase: N/A
Priority: Normal
Start: 03/12/25
End: 03/31/29
Due: 03/31/30
Phase: N/A
Priority: Normal
Start: 03/13/25
End: 04/01/28
Due: 04/01/29
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 04/04/18
End: 11/05/21
Due: 11/05/22
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 09/06/19
End: 08/05/21
Due: 08/05/22
Phase: N/A
Priority: Normal
Start: 06/11/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 11/10/17
End: 01/30/22
Due: 01/30/23
Phase: N/A
Priority: Normal
Start: 10/31/01
End: 06/30/03
Due: 06/30/04
Phase: N/A
Priority: Normal
Start: 01/17/19
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 02/17/22
End: 10/13/22
Due: 10/13/23
Phase: N/A
Priority: Normal
Start: 05/31/18
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 12/30/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 05/17/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 02/01/12
End: 11/30/21
Due: 11/30/22
Evaluation of the Safety and Tolerability of Exogenous Ketosis Induced by Free Beta-hydroxybutyrate.
Phase: N/A
Priority: Normal
Start: 10/31/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 04/04/17
End: 12/30/21
Due: 12/30/22
Phase: N/A
Priority: Normal
Start: 12/31/05
End: 01/31/07
Due: 01/31/08
Phase: N/A
Priority: Normal
Start: 01/10/20
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 11/05/23
End: 04/01/24
Due: 04/01/25
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 01/31/18
Due: 01/31/19
Phase: N/A
Priority: Normal
Start: 01/15/18
End: 02/17/18
Due: 02/17/19